MarveLab

MarveLab, founded in 2024 in Chengdu, China, is engaged in delivering innovative AI solutions to optimize business operations. The company has completed 1 deal, with the most recent occurring on February 10, 2026.Quvanai specializes in advanced artificial intelligence solutions designed to optimize operational efficiencies across various industries. Their core offerings include machine learning algorithms, data analytics platforms, and automation tools aimed at addressing complex challenges in sectors such as finance, healthcare, and logistics. These products are engineered to enhance decision-making processes, streamline workflows, and improve predictive capabilities, ultimately enabling clients to achieve greater productivity and cost savings. Quvanai’s client base includes medium to large enterprises in North America and Europe, where they deploy their technology to solve specific use cases such as risk assessment in finance, patient management in healthcare, and resource allocation in logistics.Quvanai generates revenue primarily through a subscription-based model, offering tiered pricing plans that cater to different business sizes and requirements. Clients engage in annual or multi-year contracts, which provide access to their flagship products and regular updates. The transactions typically involve direct agreements with B2B clients, allowing for tailored solutions to meet specific operational needs. Revenue streams are also supported by strategic partnerships that enable Quvanai to integrate its solutions into broader enterprise systems, thus enhancing their service offerings. MarveLab is also targeting expansion into new markets, although specific regions have not been disclosed, with initiatives expected to launch as they develop their product offerings.

1. Angel

   Feb 10, 2026

   Amount

   Undisclosed

   Investors

   Locked